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The cxtracrllular fluid phase marker, horseradish peroxidasc, enters chromaffin cells when triggered tosecrete catecholaminc. This triggered uptake, 
like secretion. isabolished in cells prr-incubated with botulinurn toxin. Endocytosis of horseradish peroxidasc into unstimulatcd cells is unaffected 
by botulinum toxin but is inhibited when the temperature is reduced. Once inlernalised by the unstimulated cells, horseradish peroxidasc isreleased 
back into the extracellular fluid, the rate of release being temperature s nsitive but unaffcctcd by carbamylcholine orbotulinum toxin. These results 
supgcsl that triggered exocytosis i  a necessary event to precede triggered endocytosis, and that botulinum toxin may aft&t only the triggered 
cxacytosis/endocytosis cycle and not the constitutivc ycle. 
Endocytosis: Vesicular, Botulinurn toxin; Exocytosis; Chromaffin cell; Fluid phase uptake 
1. INTRODUCTION 
Most cells continuously undergo cycles of cxocytosis 
and endocytosis, and in some cases the turnover of 
extracellular fluid is quite large. For example, using 
horseradish peroxidase (HRP) as a fluid phase marker, 
it has been estimated that about 25% of the cell volume 
of fibroblasts is taken up over a period of 3-6 h [l-S] 
and that this fluid phase uptake is balanced by exo- 
cytosis, with 20-50% of intrrnalised tracers released 
back into the extracellular fluid within 3-10 min [3,6,73. 
downstream of the calcium transient, at or near the site 
of exocytosis in chromaffin cells [lo], provides a tool to 
investigate this further. 
This paper therefore describes experiments that 
address two questions: (i) Does botulinum toxin inhibit 
triggered endocytosis of HRP as well as triggered exo- 
cytosis in chromaffin cells? and (ii) what is the effect of 
the toxin on the basal uptake of HRP into, and subse- 
quent release from, unstimulated cells? 
This activity, termed constitutive exocytosis/endo- 
cytosis, is distinct from regulated exocytosis/endo- 
cytosis which occurs in cells containing specialised se- 
cretory vesicles. These cells can release the contents of 
their vesicles by exocytosis in response to external 
stimuli. In chromaffin cells, for example, up to 30% of 
the cellular catecholamine can be released in a short 
time in response to cholinergic stimulation. The same 
stimulus triggers not only exocytosis but also endo- 
cytosis. 
The results show that botulinum toxin blocks 
triggered endocytosis as well as exocytosis, and are con- 
sistent with the idea that triggered exocytosis is a neces- 
sary event to precede endocytosis. The data strongly 
suggest that botulinum toxin does not block un- 
triggered, constitutive fluid phase exocytosis and endo- 
cytosis. 
2. MATERIALS AND METHODS 
2. I. Sohriorrs and ckmiculs 
Recent studies, directed towards dissecting the in- 
tracellular factors controlling these two events, used 
horseradish peroxidase (HRP) as a marker of fluid 
phase uptake, as it allowed the rapid kinetics of endo- 
cytosis to be studied [8]. HRP, however, detects all types 
of endocytosis [9], and so it was possible that cholinergic 
activation of the cell triggered endocytosis which was 
independent of triggered exocytosis. The discovery that 
botulinum toxin type D blocks exocytosis by acting 
Physiological saline contained !50 mM NaCI,S mM KCI. 10 mM 
glucose, 2.5 mM CaCI:, I ,8 mM MgCI,, 0. I % bovine serum albumin 
(BSA), IO mM KEPES, pH 7,3. 
In solutions containing zero calcium, Ca was rcplaccd by Mg and 
5 mM EGTA was added. 
All chemicals, except for botulinum toxin, were obtained from 
Sigma. 
Purified botulinurn toxin ~ypc D was obtained from Wako Co.. 
Japan, In some expcrirnents unpurified D toxin (a gift from Dr E. 
Schante, Wisconsin, USA) containing an ADP-ribosyltransferase 
component wus used [I I]. The results described in this paper arc from 
experiments using purilied toxin. Similar results were obtained using 
the unpurified form. 
Corre.~potrdencc nddrew D-E, Knight, Division of Biomedical 
Scicnccs, King’s College London, London W8 7AH, UK. Fax (44) 
2.2. Prcpurrrrion of cells and e.qwritnerrral procedures 
(71) 937 7183. 
Cells were isolated and cultured in multiwell culture plates for 3-5 
days at a density of IO’ cclls/wcll as described previously [I_71 and in 
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the presettee of various concentrations of botulinurn toxin [13]. A 
chromaffin cell suspension, carefully and freshly prepared from 
medullary tissue, is relatively pure, with non-chromaffin cells occupy- 
ing only about 20% of the population [14], Such purity is achieved by 
using only ‘white’ medullary tissue free from the obvious darker corti- 
cal tissue, and the use of Percoll gradients to further purify the cells. 
tognher with the use of cylosinc arabinoside to prevent proliferation 
of contaminating cells in culture, e.g. fibroblasts, ensure that our cell 
preparation is essentially chromaffm cells [12]. 
Cateeholaminc secretion, and horseradish peroxidase (HRP) 
uptake and release were followed as described previously [12]. Basal 
secretion of HRP was followed after pre-loading the cells by a 30 min 
incubation at 23°C with HRP (I mgml) and subsequent removal of 
extraoellular label with three washes in physiological saline. 
3. RESULTS 
3.1. ~cttech&tnine refeuse and horsemdisi~ peroxidasr 
uptake 
Fig. la and b show that carbamylcholine triggers 
both catacholamine secretion from, and HRP uptake 
into, cultured chromaffn cells, with the onset of HRP 
uptake slightly lagging behind the faster onset of cate- 
cholamine release. Unstimulated cells also release a 
small amount of catecholamine, i.e. less than 4% of the 
cellular content per h. The same sample of unstimulated 
cells also take up a small amount of extracellular horse- 
radish peroxidase, but here the ratio of basal uptake to 
basal carec~~~fsmine z&ase is markedly greater than chz 
ratio of evoked HRP uptake to evoked catecholamine 
release. The time-course of basal HRP uptake and 
basal catecholamine release were similar, both being 
linear over 20 min. 
Fig. 2 shows that the amount of HRP that entered 
both stimulated and unstimulated cells was linearly de- 
pendent on the ~xtrecellular concentration of HRP dur- 
ing uptake, indicating that HRP enters the cell predo- 
minantly by fluid phase uptake. 
Carbamylcholine-evoked catecholamine r lease and, 
consequently, HRP uptake were dependent on extracel- 
lular calcium. Basal HRP uptake was less so, however. 
The carbamylcholine-evoked responses were reduced 
by over 95% when the extracellular calcium was de- 
creased from 3 mM to close to 1 nM (5mM EGTA and 
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Fig. 1. Botulinum loxin blocks triggered HRP uptake and catecholaminc secretion form chromalbn cells. Chromaftin cells were cultured for 5 days 
alone (a, b) or in the presence (c. d) of SOp@ml of botulinum toxin type D. They were then incubated in HRP (1 mg/ml) and challenged with 100 
PM carbamylcholine at23OC. Cells challenged with carbamylcholine ( .~). Unchallenged cells (0.0). At the various times shown the amounts oi 
HRP taken up into cells (a$) and the amounts ofcatacholamine secreted from these cells (b,d) were measured. Some cells (a), not challenged with 
carbamylcholinc, were incubated with HRP at 0°C and the uptake measured (e). The catecholaminc secrctcd is cxpresscd as a percentage of the 
total cellular content, and the amount of HRP taken up is expressed as a volume ofcxtracellular Ruid (I ml of Ruid corresponding to I mgof MRP). 
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Fig. 3. The HRP taken up into stimulated and unstimulatcd cells 
represents fluid phase uptake. The amount of HRP taken up at 23OC 
over 10 min into unstimulatcd cells (0) or into cells stimulated with 
100 yM carbamylcholine (0). is plotted against he concentration of 
HRP present in the extracellular fluid during the IO n-tin incubation. 
no added calcium), but the basal uptake of HRP was 
changed by less than 10% over the same decrease in 
extracellular calcium. 
3.2. Tile effecr ofbotulinm roxin on [riggered mid non- 
triggered cndocytosis 
Fig. Ic and d show that incubation of cells for 5 days 
with botulinum toxin type D (SO j&//ml) completely 
abolished the stimulation-dependent components of 
both catecholamine secretion and fluid phase uptake. 
The uptake into toxin-treated, stimulated cells was not 
significantly different (P > 0.05) from the basal uptake 
into toxin-treated or untreated cells (Table 1). 
The effect of varying the concentration of toxin on 
catecholamine secretion and HRP uptake is shown in 
Fig. 3. Increasing concentrations of toxin reduced the 
stimulation-dependent components of both catecho- 
lamine secretion and HRP uptake. The dose-response 
Table 1 
Rate of fluid phase uptake (measured by uptake of HRP) into bovine 
chromaffm cells 
Carbamyl- Unstimulated cells 
choline-stimu- 
lated cells 
+ toxin + toxin - toxin 
nllmin uptake 0.109 (0.014) 0.124 (0.014) 0.149 (0.017) 
(SD., n=6) 
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Fig. 3. The sensitivity to botulinum toxin type D of HRP uptake and 
catecbolamine secretion. Cells, pre-incubated for 3 days in various 
concentrations oftoxin, were exposed for 20 min to solutions contain- 
ing I mdml of HRP together with (e,& or without (0) 100 PM 
urbamylcholine. Uptake of HRP (a) and secretion of catecholamine 
(b) are shown. The data are the means (S.E.M.) of 4 determinations 
and are expressed relative to the levels of HRP uptake and catechol- 
amine secreted in the absence of botulinurn toxin. Temperature 33OC. 
curves were very similar. Basal uptake of HRP was not 
altered by any concentration of toxin used. 
Similar results to those shown in Fig. 1 and 3 were 
obtained with unpurified D toxin, which also contained 
the ADP-ribosyltransferase component. Again, toxin 
treatment reduced HRP uptake into stimulated cells to 
the same level as that seen in unstimulated cells. 
We have previously shown that HRP taken up by 
triggered endocytosis rapidly enters an intracellular 
pool that can be released back into the extracellular 
fluid by triggered exocytosis. HRP taken up into un- 
stimulated cells also enters an intracellular pool that is 
also releasable, but here the exocytosis appears to be 
constitutive [123. Fig. 4 is consistent with this and shows 
that as much as 20% of the endocytosed HRP is released 
back into the extracellular fluid over a 15 min period, 
and although temperature-sensitive, the secretory 
response is unaffected by levels of carbamylcholine that 
trigger catechoiamine secretioil. The fipre also S~CVV’S 
that this component of HRP secretion is unaffected by 
levels of botulinum toxin that strongly inhibit triggered 
catecholamine secretion. 
FEDS LETTERS February 1992 Volume 298, number 2,3 
0 
-3-e-8 
I I 1 t 
[/, 
1s 
, , 
0 5 10 0 5 10 15 
minutar minutes 
Fig. 4. Release of HRP taken up into unsiimulated cells. Unstimulated cells, pre-incubated with or without botulinum toxin, as described in the 
legend to Fig. 1, were loaded with HRP by a 30 mitr incubation in I mg/ml of the enzyme. Some cells were then challenged with LOO yM 
carbamycholine, and the evoked and basal release of (a) HRP and (b) catecholamine was followed over 15 min al 23% Cells stimulated with 
carbamylcholinc (0); unsiimulated cells (cJ); HRP release from unstimulated cells held at O’C over ihe 15 min period (G); unstimulat& toxin-treated 
cells (0). The amounts of HRP and catccholaminc secreted are expressed as persentagcs of the total cellular content. Data arc means (S.E.M.) of 
4 dctcrminalions. 
4. DISCUSSION 
Horseradish peroxidase is a very water-soluble pro- 
tein with a molecular weight of 40 kDa. Proteins of this 
size are unlikely to cross biological membranes easily 
unless they are unfolded and translocated by special 
transporters. Thus HRP has been used extensively to 
monitor fluid phase endocytosis [9]. An earlier study 
provided evidence that chromaffin cells possessed a 
stimulation-independent constitutive pathway of endo- 
cytosis as well as a pathway associated with triggered 
exocytosis, and that furthermore the continuous re- 
moval of membrane area from the cell surface by con- 
stitutive endocytosis was balanced by constitutive xo- 
cytosis. Although there was evidence that, as far as the 
triggered exocytosislendocytosis secretory cycle was 
concerned, the nature of the endocytosis vesicle was 
partly made up of secretory vesicle membrane [12], 
there remained the possibility that some of the retrieved 
membrane was derived from sources other than se- 
cretory vesicle membrane. Thus a scheme could be en- 
visaged whereby endocytosis occurred independently of 
the cxocytotic event, but that was nevertheless triggered 
by intracellular conditions that also favoured exo- 
cytosis. 
The observation here that rapid, triggered HRP 
uptake is botulinum toxin sensitive gives no support to 
this idea. Botulinum toxin acts downstream of the Ca’+ 
transient, probably at or near the site of exocytosis [lo], 
and the finding that it also abolishes the stimulation- 
dependent increase of fluid phase uptake is entirely con- 
sistent with a model in which triggered exocytosis is a 
necessary event for triggered endocytosis to occur. This 
finding hXefOik? knbs ix support tc the idea that in 
chromaffin cells endocytosis of membrane other than 
secretory vesicle membrane is triggered by an intracel- 
lular signal generated after receptor activation. In parti- 
cular it is evident that the calcium signal, still present 
in botulinurn toxin-treated cells, is not sufficient to 
trigger endocytosis. Although increasing concentrations 
of botulinum toxin reduced triggered IiRP uptake to 
the level found in unstimulated cells, the uptake into 
these unstimulated cells is unaffected by the toxin. Botu- 
linum toxin may therefore distinguish between constitu- 
tive endocytosis and endocytosis associated with 
triggered exocytosis. The export of the fluid phase 
marker taken up by constitutive ndocytosis i  neither 
inhibited by the toxin nor stimulated by carbamyl- 
choline. A likely explanation to the data therefore is that 
botulinum toxin does not block the constitutive xo- 
cytosis/endocytosis cycle, and that the pools of vesicles 
undergoing triggered secretory cycles are distinct from 
the vesicles undergoing constitutive secretory cycles. 
Basal release of catecholamine is very low, and so in- 
hibition by botulinum toxin is not easy to detect using 
fluorimetric techniques. In studies using cells labelled 
with [‘Hjnoradrenaline, levels of toxin that fully in- 
hibited triggered noradrenaline release inhibited about 
half the basal release [13]. One explanation for this is 
that about half the basal release arises from catechol- 
amine in a botulinum-insensitive, constitutive pool of 
vesicles and the other half from a triggered pool of 
vesicles [ 151. 
The possible coexistence of two distinct secretory sys- 
tems with differential sensitivity to botulinum toxin 
within the same cell implies that botulinum toxin may 
not block all forms of exocytosis. If there are multiple 
mechanisms for membrane fusion, no statements can be 
made for the site of action of this toxin exept hat it may 
affect only one type of membrane fusion. If on the other 
hand there is a common mechanism for membrane fu- 
sion then our results suggest that botulinurn toxin does 
not block this membrane fusion step itself but interferes 
with the triggering mechanism for fusion. 
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